R0043/2026-04-01/Q002
Query: Using the vocabulary identified in Q1, search for enterprise requirements, procurement specifications, regulatory guidance, or deployment standards that address the sycophancy phenomenon under its domain-specific names. Focus on regulated industries (defense, healthcare, finance, aviation) where agreeable-but-wrong AI output could cause harm.
BLUF: No regulatory framework directly addresses "sycophancy" by name. Four indirect regulatory mechanisms provide partial coverage: EU AI Act (automation bias awareness), NIST AI 600-1 (confabulation/information integrity), SR 11-7 (effective challenge), and FDA (human factors evaluation). The gap is specifically at the intersection of model behavior and regulatory language — regulations address human responses and output quality but not the model tendency to prioritize agreement over accuracy.
Probability: N/A (open-ended query) | Confidence: Medium
Summary
Hypotheses
| ID |
Hypothesis |
Status |
| H1 |
Direct sycophancy requirements exist in regulated industries |
Eliminated |
| H2 |
No requirements address the phenomenon at all |
Eliminated |
| H3 |
Indirect coverage exists but does not name the model behavior |
Supported |
Searches
| ID |
Target |
Results |
Selected |
| S01 |
Regulatory standards across 4 industries |
40 |
6 |
| S02 |
Enterprise procurement specifications |
10 |
0 |
Sources
| Source |
Description |
Reliability |
Relevance |
| SRC01 |
EU AI Act Article 14 |
High |
High |
| SRC02 |
NIST AI 600-1 |
High |
Medium-High |
| SRC03 |
SR 11-7 effective challenge |
High |
Medium-High |
| SRC04 |
FDA AI device guidance |
High |
Medium |
| SRC05 |
IEEE 3119 procurement |
High |
Medium |
| SRC06 |
Georgetown regulatory gap analysis |
Medium-High |
High |
Regulatory Coverage Map
| Regulation/Standard |
What It Addresses |
What It Misses (re: Sycophancy) |
| EU AI Act Art. 14 |
Human automation bias awareness |
Model behavior that induces automation bias |
| NIST AI 600-1 |
Confabulation, information integrity |
Agreement-seeking (vs. factual errors) |
| SR 11-7 |
Independent validation, effective challenge |
Model tendency to resist challenge |
| FDA AI guidance |
Human factors, accuracy metrics |
Acquiescence/deference in clinical AI |
| IEEE 3119 |
Procurement process structure |
Sycophancy evaluation criteria |
Revisit Triggers
- EU AI Act implementing rules or guidance published that specify sycophancy testing
- NIST AI RMF or 600-1 updated to include sycophancy or agreement-seeking as a risk category
- SR 11-7 supplement or update addressing generative AI model behaviors
- FDA finalization of AI/ML device guidance with sycophancy provisions
- Major AI incident in a regulated industry attributed to sycophantic model behavior